Mode
Text Size
Log in / Sign up

Evaluating the Efficacy of Outpatient CT Coronary Angiography in Acute Coronary SyndromeCT scans do not reduce heart attack risk in emergency care

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Outpatient CT coronary angiography did not significantly reduce the risk of cardiac death or myocardial infarction.

This large-scale randomized controlled trial investigated the clinical utility of outpatient computed tomographic (CT) coronary angiography for patients presenting with suspected acute coronary syndrome. The study specifically targeted a high-risk cohort: patients where myocardial infarction had been ruled out, but high-sensitivity cardiac troponin testing indicated an intermediate risk of a major cardiovascular event. By enrolling 3,170 patients across 14 UK hospitals, the researchers aimed to determine if guided imaging could improve long-term outcomes compared to standard care.

The primary endpoint was a composite of cardiac death or myocardial infarction over a median follow-up period of 3.0 years. This timeframe is significant for assessing the durability of management strategies in patients with intermediate risk profiles. The study design allowed for a robust comparison between the intervention group and the standard care cohort, providing a clear look at the impact of early imaging guidance on patient mortality and morbidity.

Results indicated that the incidence of the primary composite outcome was nearly identical between the two groups. Specifically, 7.1% of patients in the CT coronary angiography group experienced a major cardiac event compared to 7.3% in the standard care group. The hazard ratio of 0.95 (95% CI, 0.73 to 1.23; P = 0.71) confirms that the addition of outpatient CT angiography did not significantly alter the rate of adverse cardiac events in this specific population.

From a safety perspective, the intervention was well-tolerated. Only 0.4% of participants in the CT coronary angiography arm experienced an adverse event related to the imaging procedure. This suggests that while the procedure is safe, it does not provide a statistically significant advantage in preventing long-term cardiac complications when compared to standard clinical pathways for intermediate-risk patients. Clinicians must consider these findings when managing patients with suspected acute coronary syndrome who fall into the intermediate risk category. While CT coronary angiography is a highly effective diagnostic tool for identifying coronary anatomy, its role as a primary driver for improving long-term survival or reducing the frequency of major cardiac events in this specific cohort is not supported by this data. The results suggest that standard care remains a robust pathway for these patients.

In conclusion, the study provides evidence that routine CT coronary angiography-guided management does not result in a lower incidence of cardiac death or myocardial infarction than standard care. The findings emphasize that while imaging is a valuable diagnostic component, it does not fundamentally change the primary outcomes for patients with intermediate risk profiles. These results can help clinicians manage expectations regarding the impact of imaging on long-term outcomes in the outpatient setting.

When someone experiences sudden chest pain or signs of a heart emergency, every second counts. Doctors must decide quickly how to treat the patient. One method involves using a CT coronary angiography, which is a type of specialized scan that looks at the heart's blood vessels. Some experts have wondered if using these scans to guide treatment helps patients avoid future heart attacks or death compared to standard medical care. This research was designed to see if that specific technology actually changes the outcome for people in high-risk situations.

To find the answer, researchers conducted a large trial involving 3,170 patients across 14 hospitals in the United Kingdom. These patients were experiencing symptoms of acute coronary syndrome, which is a sudden drop in blood flow to the heart. They were specifically chosen because their initial tests showed they were at an intermediate risk for a major heart event. The study followed these patients for a median of about three years to see how they fared under two different management styles: one guided by the CT scans and one using standard care.

The results of the study showed no significant difference between the two groups. In the group that received care guided by CT scans, 112 people (about 7.1 percent) suffered a heart attack or died from a heart-related cause. In the group receiving standard care, 116 people (about 7.3 percent) faced the same outcomes. Because these numbers were so close, the study concluded that using the CT scan to guide management did not result in a lower rate of heart attacks or deaths compared to the standard way of treating patients.

Regarding safety, the study reported that only a very small number of people, about 0.4 percent, experienced an adverse event specifically related to the CT scan. This suggests the procedure was generally well-tolerated by the patients during the study period.

It is important to remember that while this study is large, it is just one piece of the puzzle. It specifically looked at patients with an intermediate risk of a heart event. For patients currently experiencing a heart emergency, this means that while the extra step of a CT scan is a common tool, it did not change the overall survival rates or the frequency of heart attacks in this specific group. Doctors will continue to use the best tools available to stabilize patients and provide life-saving care.

What this means for you:
CT scans used to guide care did not lower the risk of heart attacks compared to standard care in this study.

Study Details

Study typeRct
Sample sizen = 3,170
EvidenceLevel 2
Follow-up732.0 mo
PublishedNov 2026
View Original Abstract ↓
BACKGROUND: Many patients with suspected acute coronary syndrome in whom myocardial infarction has been ruled out in the emergency department remain at risk for cardiovascular events. Whether further investigation reduces this risk is unknown. METHODS: In a multicenter, randomized, controlled trial, patients who presented to an emergency department in 14 hospitals across the United Kingdom were enrolled if myocardial infarction had been ruled out and high-sensitivity cardiac troponin testing indicated an intermediate risk of a cardiovascular event (maximum high-sensitivity cardiac troponin I or T concentration, >5 ng per liter). Participants were randomly assigned in a 1:1 ratio to receive either outpatient computed tomographic (CT) coronary angiography-guided care or standard care. The primary outcome was a composite of myocardial infarction or death from a cardiac cause. RESULTS: From September 18, 2019, to May 11, 2023, a total of 3170 participants (median age, 61 years; female sex, 30.2%) were assigned to undergo CT coronary angiography (1587 participants) or receive standard care (1583 participants). At 90 days after randomization, CT coronary angiography had been performed in 1462 participants (92.1%) in the CT coronary angiography group and in 35 participants (2.2%) in the standard-care group. Overall, 7 participants (0.4%) had a CT coronary angiography-related adverse event. After a median of 3.0 years, at which point the number of primary-outcome events in the standard-care group exceeded the prespecified minimum of 97, a primary-outcome event had occurred in 112 participants (7.1%) in the CT coronary angiography group and in 116 (7.3%) in the standard-care group (adjusted hazard ratio, 0.95; 95% confidence interval, 0.73 to 1.23; P = 0.71). CONCLUSIONS: In patients with suspected acute coronary syndrome in whom myocardial infarction had been ruled out, routine CT coronary angiography-guided management did not result in a lower incidence of subsequent myocardial infarction or death from a cardiac cause than standard care. (Funded by the British Heart Foundation; TARGET-CTCA ClinicalTrials.gov number, NCT03952351.).
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.